Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT in connection with the acquisition of Anticimex
Mandate

Vinge advises EQT in connection with the acquisition of Anticimex

June 09, 2021 Employment and Benefits Banking and Finance Commercial Agreements EU, Competition and Regulatory Intellectual Property M&A Insurance Law IT, Telecommunications and Outsourcing

Vinge advises EQT in connection with the acquisition of leading global pest control specialist Anticimex which becomes the first investment of EQT’s new purpose-driven strategy with longer-term investments and impact at its core.

Anticimex is a modern service company working with pest control, food safety, damp control, house inspections and fire protection. Anticimex has since 1934 developed from being a Swedish family business to an international company with over 4,500 employees in 17 countries. The transaction, where the selling party is the EQT VI fund, has an enterprise value of SEK 60 billion and the investment is made together with several long-term investors, such as Melker Schörling AB (MSAB), who will be the second largest shareholder, GIC, AMF, Interogo Holding Long-Term Equity and Alecta.

Vinge’s team consists of Christina Kokko and Peter Sundgren together with Maria Dahlin Kolvik, Ellinor Wargenbrant, Manne Bergström and Nando Basic (M&A/Corporate), Louise Brorsson Salomon, Seyran Sahin, Karl-Gustaw Tobola and Axel Jansson (Banking and Finance), Viveka Classon, Paulina Malmberg and David Lundahl (Corporate Insurance), Emma Stuart-Beck, Caroline Krassén and Elias Bohlin (Financial Services), Sofia Bergenstråhle (IPR), Isabell Nielsen (Commercial Agreements), Elin Broman (Employment), Lina Österberg and Ulf Pyk (Real Estate and Environment), Mika Jordan (IT), Nicklas Thorgerzon (GDPR) and Jessica Öijer (VDR). Partner Marcus Glader together with Emma Johansson and Johan Wahlbom advice in relation to merger filing.

Related

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

 The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

 Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026